Schedule 13G ownership disclosure

Haemonetics Corp

COMMON STOCK · CUSIP: 405024100

Event date: 2025-03-31

Filing-level shares
2,195,569
Percent of class
4.4%
  • T. Rowe Price Investment Management, Inc.

    Shares: 2,195,569 · Class: 4.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-25-000181
Form type
SCHEDULE 13G/A
Filer
HAEMONETICS CORP
CIK
CIK 313143
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub